Becton Dickinson & Co. (NYSE:BDX) said Wednesday it opened an advanced diabetes care facility in Andover, Mass., which will serve as the headquarters for BD’s advanced diabetes care platform.
The facility will house BDs research and development and manufacturing for its Type 1 and Type 2 diabetes treatments and devices, the Franklin Lakes, N.J.-based company said.
“The opening of this facility represents an exciting opportunity for BD to accelerate the development of next-generation technologies to help simplify the management of Type 1 and Type 2 diabetes. This new model will help increase the rate of innovation and enable us to provide therapeutic advances in the diabetes care sector,” chief medical officer Dr. Ellen Strahlman said in a press release.
Last month, Medtronic (NYSE:MDT) and BD’s medical division said they’re collaborating to produce and market a new insulin pump infusion set. The deal calls for Medtronic to commercialize the set, with BD Medical manufacturing the product, the companies said. The device will utilize BD’s FlowSmart technology, which features a side-ported catheter designed to improve insulin flow and reduce flow interruptions.
The post Becton Dickinson opens diabetes HQ in Andover appeared first on MassDevice.
from MassDevice http://ift.tt/1SrSUg9
Cap comentari:
Publica un comentari a l'entrada